1. China Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
HuBei NengTer Technology CO.,Ltd Class A

HuBei NengTer Technology CO.,Ltd Class A

SSZSE:002102
2.43
CNY
0.00
(0.00%)
0.00EPS
5.30BMarket Cap
Oct 27Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.55
1.1
1.84
0.4
3.72
5.43
6.05
4.88
5.14
4.66
3.69
3.9
2.9
2.35
Basic EPS, GAAP
0.02
- -
0.27
0.11
0.11
-1.03
0.26
0.05
0.04
0.17
0.09
-0.23
0.1
-0.01
Free Cash Flow per Basic Share
0.01
-0.11
-0.09
-0.15
-0.02
0.01
0.28
0.31
0.01
-0.34
0.3
- -
-0.18
- -
Dividend per Share
0.04
0.04
0.13
0.03
0.03
0.06
0.02
0.01
0.02
0.02
0.02
0.02
0.01
- -
Book Value per Share
0.53
1.08
1.31
2.08
2.02
0.94
1.21
1.26
1.3
1.47
1.55
1.32
1.24
1.22
Tangible Book Value per Share
0.49
0.2
0.62
0.8
0.95
-0.1
0.42
0.51
0.61
0.85
0.99
1.05
1.03
1.01
Basic Weighted Avg Shares
1,202
1,707
716
2,191
2,616
2,634
2,634
2,631
2,632
2,633
2,620
2,633
2,510
2,435
Sales/Revenue/Turnover
1,867
1,874
1,316
887
9,736
14,293
15,936
12,842
13,533
12,260
9,658
10,262
7,272
5,712
Operating Margin (%)
-1.18
1.2
6.17
21.44
4.69
3.38
3.9
2.15
2.04
1.49
1.38
1.04
- -
0.81
Depreciation Expense
22
25
69
52
96
111
108
75
101
136
140
143
144
- -
Net Income, GAAP
28
6
193
245
283
-2,712
689
126
101
444
238
-600
248
-13
Effective Tax Rate (%)
33.08
89.88
15.32
21.25
12.92
- -
11.8
21.23
35.42
8.59
8.8
- -
1.81
142.09
Profit Margin (%)
1.5
0.3
14.69
27.66
2.9
-18.98
4.32
0.98
0.75
3.63
2.46
-5.85
3.42
-0.23
Working Capital
-522
-442
574
590
675
-1,115
-952
-1,934
-868
591
561
594
220
504
LT Debt
22
646
734
746
441
320
126
381
643
924
201
217
189
169
Total Equity
683
2,058
2,909
4,587
5,341
2,443
3,317
3,431
3,552
4,015
4,265
3,678
3,270
3,225
Return on Invested Capital (%)
0.83
0.03
3.46
3.72
4.39
- -
16.6
4.82
2.02
9.18
3.5
- -
5.58
-0.11
Return on Capital (%)
5.29
0.71
7.41
5.91
5.64
- -
20.09
4.16
2.52
9.48
5.09
- -
5.82
-0.76
Return on Common Equity (%)
4.38
0.42
7.89
6.62
5.73
-69.79
24.4
3.86
3
12.21
5.99
-15.92
7.59
-0.42

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,044
1,043
971
LT Borrowings
189
190
169
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,476
2,476
2,476
Market Capitalization
8,244
8,021
5,298

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,281
3,708
3,229
Cash, Cash Equivalents & STI
999
1,223
798
Accounts Receivable, Net
454
560
502
Inventories
1,199
1,253
1,316
Total Current Liabilities
3,061
3,064
2,726
Payables & Accruals
- -
- -
- -
ST Debt
1,044
1,043
971
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.7%
-0.41%
-11.09%
Free Cash Flow
1,666.14%
2,798.06%
17,632.91%
Net Income, GAAP
-144.54%
-44.05%
-141.4%
Sales/Revenue/Turnover
95.55%
-9.63%
-29.14%
Total Cash Common Dividend
2.88%
0.37%
-29.34%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,540
3,190
3,057
974
10,262
2025
2,319
1,932
1,528
1,492
7,272
2026
1,521
1,171
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
- -
0.02
-0.27
-0.23
2025
0.09
0.05
0.05
-0.09
0.1
2026
0.01
0.03
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
- -
- -
0.02
2025
- -
0.01
- -
-0.01
0.01
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yong Chen
Full Time Employees
931
Sector
Process industries
Industry
Chemicals: specialty
Address
Building 8 Jingzhou HB China 434000
IPO Date
Dec 29, 2006
Website
guanfu.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Dow Inc. (NYSE:DOW)
Business
HuBei NengTer Technology CO.,Ltd (002102.SZ), formerly known as Guanfu Holding Co., Ltd., operates as a diversified biotechnology and e-commerce platform company focused on pharmaceutical intermediates, chemical engineering, plastic raw materials supply chain services, and ancillary activities including real estate leasing and gold mining; founded in 1999 and headquartered in Jingzhou, Hubei Province, China, it conducts primary operations through core subsidiaries Nengte Technology Co., Ltd., which develops and produces global pharmaceutical raw materials, animal nutrition additives, and new material products, and Shanghai Sumi Information Technology Co., Ltd., which runs a B2B e-commerce platform for the plasticization industry; main products encompass montelukast sodium intermediates, rosuvastatin series intermediates, vitamin E and its intermediates, alongside plastic trade services and mining outputs, with sales predominantly in China supplemented by overseas markets. The company serves pharmaceutical manufacturers, animal nutrition providers, plastic processors, and industrial clients across domestic and select international segments, reporting 2024 revenues with plastic trade e-commerce at approximately CNY 11.18 billion, pharmaceutical and chemical engineering at CNY 1.06 billion, and total geographic sales led by China at CNY 12.07 billion plus overseas contributions of CNY 213 million. Recent developments include an ongoing equity buyback plan tranche update in October 2025, board changes, and sustained promotion of vitamin E projects and plastic trading platforms like "Plastic Rice City," alongside divestitures such as the prior sale of Shanghai Sumi Information Technology Co., Ltd. and Shaanxi Ankang Shengan Mining Co., Ltd., reflecting strategic restructuring in its multi-segment operations.